Advertisements


We are Sorry, This Page doesn't Exist


Insulet and West Pharma Proven Winners in Growing Wearable Devices Market

The companies are well positioned to continue to benefit from the demand for on-body drug delivery systemsRelated Stocks: PODD, WST, AMGN, BDX, CSRT.L, SNY,.....»»

Category: worldSource: nytMay 15th, 2019

Drug/Biotech Stock Q1 Earnings on May 9: IONS, XLRN & More

Five drug/biotech stocks are scheduled to release their first-quarter results on .....»»

Category: smallbizSource: nytMay 8th, 2019

Gilead Sciences Rises on 1st-Quarter Results

Major drug manufacturer beats earnings forecastsRelated Stocks: GILD,.....»»

Category: personnelSource: nytMay 3rd, 2019

Amgen Falls on 1st-Quarter Results

The US multinational biopharma company beats forecasters on earnings and revenueRelated Stocks: AMGN,.....»»

Category: dealsSource: nytMay 1st, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs

Biotech stocks staged a recovery this week after being in the red in the previous two weeks. AbbVie Inc (NYSE: ABBV)'s psoriasis drug Skyrizi received FDA nod. The week also saw the release of strong quarterly earnings by big European pharma gian.....»»

Category: earningsSource: benzingaApr 27th, 2019

What"s in Store for Vertex (VRTX) This Earnings Season?

On Vertex's (VRTX) first-quarter earnings call, investor focus will be on its latest CF drug Symdeko's sales figure as well as the update on its CF triple-pill r.....»»

Category: personnelSource: nytApr 24th, 2019

The Daily Biotech Pulse: FDA Greenlights AbbVie"s Psoriasis Drug, Novartis Earnings, Patent Notification For MediciNova

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on April 22) read more.....»»

Category: blogSource: benzingaApr 24th, 2019

Amgen Beat Consensus on Earnings and Sales

Amgen released figures for the first quarter of 2018Related Stocks: AMGN,.....»»

Category: smallbizSource: nytApr 25th, 2018

Drug/Biotech Stock Q1 Earnings Due on Apr 24: LLY, BIIB, AMGN

Three pharma/biotech bigwigs are set to release .....»»

Category: dealsSource: nytApr 23rd, 2018

Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices

Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices.....»»

Category: topSource: seekingalphaApr 21st, 2018

5 Drug Stocks Poised to Surpass on Earnings This Quarter

The outlook for the upcoming first-quarter results looks bright. The first-quarter earnings season has just kicked off. Per the latest Earnings Preview, the bottom line of S&P 500 companies is expected to increase at a highly impressive rate of.....»»

Category: personnelSource: nytApr 17th, 2018

Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More

Four pharma/biotech companies are set to release earnings .....»»

Category: personnelSource: nytApr 30th, 2018

Drug Prices Too High? Don’t Blame Rebates. Blame the FDA Approval Process

Both biotech and pharma may soon come under a pricing attack, and it could endanger future research initiatives and the flow of new drugs to marketRelated Stocks: ESRX, VRTX,.....»»

Category: dealsSource: nytMay 10th, 2018

Tax Repatriation of Foreign Earnings: How Will Corporations Spend Billions in Cash Savings?

Now that hundreds of billions in cash will be flowing back to the coffers of US corporations, how will the money be spent? Dividends? Share buybacks? M&A activity?Related Stocks: AAPL, MSFT, CSCO, AMGN,.....»»

Category: dealsSource: nytMay 10th, 2018

Europe Approves Expanded Label for Amgen Drug

The European Commission gives approval to a drug that is used to treat cardiovascular diseaseRelated Stocks: AMGN,.....»»

Category: smallbizSource: nytMay 17th, 2018

London Markets: U.K. stocks fall from record as AstraZeneca, oil stocks decline

U.K. stocks on Friday pulled back from a record close, as shares of AstraZeneca declined following the heavyweight drug maker’s earnings report, and as shares in oil companies took a break from their recent rally......»»

Category: topSource: marketwatchMay 18th, 2018

Amgen Drug Receives Approval

The approval for the drug used to treat a rare form of leukemia is based on overall survival data from the Phase 3 TOWER studyRelated Stocks: AMGN,.....»»

Category: blogSource: gurufocusJun 20th, 2018

Amgen: Don’t Sleep on This Biotech Giant

Earnings, assets and growth potential make for a tempting playRelated Stocks: AMGN,.....»»

Category: blogSource: gurufocusJun 28th, 2018

Drug Stocks to Report Q2 Earnings on Jul 31: PFE, INCY, ECYT

Let's see how pharma/biotech stocks.....»»

Category: smallbizSource: nytJul 30th, 2018

US Stocks Higher Wednesday

AAR Corp stock rose on earnings beatRelated Stocks: AIR, EQT, INCY, SCG, VIAB, FL, VRTX, CTAS, KMX, COG, AMD,.....»»

Category: dealsSource: nytSep 26th, 2018